SHENZHEN, China, July 21 /PRNewswire-Asia-FirstCall/ -- Domain Registration Corp. (OTC Bulletin Board: DOMR), today announces that the Company has changed its name to "BioPharm Asia, Inc." effective July 17, 2009. A corresponding ticker change will take place in the next three to four weeks in accordance with FINRA policy.
The name change to BioPharm Asia, Inc. will be reflected in SEC filings and all future corporate communications with the investor community, including press releases and the Company's new and evolving website: http://www.biopharmasiainc.com .
"In order to more accurately reflect our Company's broad initiatives into the pharmaceutical and medical markets, we have changed our corporate name to BioPharm Asia, Inc.," said Yunlu Yin, Chief Executive Officer. "As demonstrated by our recent announcement of 360 new retail stores opening across China's Northeast, we are committed to become a leading supplier and distributor of high quality pharmaceutical and herbal products and addressing the rising demand for these medicines throughout China. We look forward to updating our loyal shareholders and prospective investors on BioPharm Asia's exciting developments in the coming weeks and months."
About BioPharm Asia, Inc.
BioPharm Asia, Inc. is primarily engaged in the retail sale of medical
products in China, complemented by a vertically integrated supporting function
that includes the cultivation of Chinese herbal medicines, pharmaceutical
production and wholesale medicine distribution. Following several successful
acquisitions, the Company is completing the integration of its distribution
channels, and expanding its trading business (conducted through its retail
stores, and its distribution and wholesale activities) to include
pharmaceutical manufacturing and the cultivation and sale of medicinal raw
|SOURCE BioPharm Asia, Inc.|
Copyright©2009 PR Newswire.
All rights reserved